Evidence map›Paper›PMID 36673606›Full record

ArticleHealthcare (Basel, Switzerland)2023

Prevalence of Precancerous Cervical Lesions among Nonvaccinated Kazakhstani Women: The National Tertiary Care Hospital Screening Data (2018).

Balkenzhe Imankulova, Aisha Babi, Torgyn Issa, Zhanar Zhumakanova, Ljubov Knaub, Aidana Yerzhankyzy, Gulzhanat Aimagambetova

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Balkenzhe ImankulovaClinical Academic Department of Women's Health, CF University Medical Center, Astana 010000, Kazakhstan.
Aisha BabiDepartment of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.
Torgyn IssaDepartment of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0001-5214-6691
Zhanar ZhumakanovaClinical Academic Department of Laboratory Medicine, Pathology and Genetics, CF University Medical Center, Astana 010000, Kazakhstan.
Ljubov KnaubClinical Academic Department of Laboratory Medicine, Pathology and Genetics, CF University Medical Center, Astana 010000, Kazakhstan.
Aidana YerzhankyzyClinical Academic Department of Women's Health, CF University Medical Center, Astana 010000, Kazakhstan.
Gulzhanat AimagambetovaDepartment of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0002-2868-4497
Nazarbayev University · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAt the present time, cervical cancer remains the fourth most prevalent cancer among women worldwide. Most cervical cancer cases are attributed to high-risk human papillomavirus (HPV) infection. Because the natural history of cervical cancer takes decades, the disease could be prevented if premalignant conditions are identified and appropriately managed. The aim of this study is to identify the prevalence of precancerous lesions among non-vaccinated women attending the national tertiary care hospital in Kazakhstan.

methodsThis was a retrospective study of the cervical cancer screening database (2018) from the national tertiary care hospital in Kazakhstan. Records of 6682 patients, who had cervical cytology tests by Papanicolaou (Pap test), were analyzed. Out of the revised cases, 249 patients had abnormal cervical cytology reports. The Pap test was performed using liquid-based cytology (LBC). The data were analyzed using the statistical software STATA 16. A

resultsIn this retrospective analysis of 6682 patients' records, we found 3.73% (249 patients) out of all Pap tests performed in 2018 were abnormal. The prevalence of high-grade squamous intraepithelial lesion (HSIL) was high at 19.28%, and the proportion of atypical squamous cells of undetermined significance (ASCUS) and atypical squamous cells (ASCs-H) was 18.47%, while low-grade squamous intraepithelial lesion (LSIL) were identified in 62.25% of the cases. Almost 25% of the women included in the study had concurrent lower and upper genital tract infections.

conclusionAlthough the overall rate of abnormal Pap test results was not high, the study shows the elevated prevalence of HSIL. It calls the attention of local policymakers and gynecology specialists and requires immediate actions to improve the prophylactic measures to decrease morbidity and mortality from cervical cancer in Kazakhstan.

Indexed as

cervical cancerCINHSILLSILprecancerous cervical lesions

Identifiers

PMID36673606
PMCPMC9859595
OpenAlexW4316037983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.